Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › North Carolina › Durham
Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Durham, NC
Masomo 14 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Durham na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
InaajiriHatua 2
- Duke Blood Cancer Center, Durham
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
InaajiriHatua 3
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
InaajiriHatua 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · Mi 10 mbali
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
InaajiriHatua 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · Mi 10 mbali
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
InaajiriUtafiti wa uchunguzi
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
InaajiriHatua 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
InaajiriHatua 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
InaajiriHatua 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
InaajiriUtafiti wa uchunguzi
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Mi 10 mbali
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
InaajiriHatua 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
InaajiriUtafiti wa uchunguzi
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Mi 10 mbali
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
InaajiriHatua 1
- University of North Carolina, Chapel Hill · Mi 10 mbali
A Study of NX-1607 in Adults With Advanced Malignancies
InaajiriHatua 1
- University of North Carolina, Chapel Hill · Mi 10 mbali
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
InaajiriHatua 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Mi 10 mbali
Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine
- New York City, NYUtafiti 21
- Baldwin Park, CAUtafiti 19
- Chicago, ILUtafiti 18
- Houston, TXUtafiti 17
- Los Angeles, CAUtafiti 17
- Boston, MAUtafiti 16
- Milwaukee, WIUtafiti 16
- Nashville, TNUtafiti 15
- Portland, ORUtafiti 15
- Philadelphia, PAUtafiti 15
- Dallas, TXUtafiti 13
- Seattle, WAUtafiti 12
Masomo mengine katika Durham
- Saratani ya MatitiUtafiti 63
- Saratani (aina zote)Utafiti 58
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 39
- Multiple MyelomaUtafiti 37
- Saratani ya MetastasiUtafiti 33
- Leukemia ya Myeloid ya GhaflaUtafiti 33
- Saratan ya MapafuUtafiti 32
- Saratani ya ProstateUtafiti 32
- Kansari ya kolorektaliUtafiti 28
- Leukemia ya Limfosaiti ya Muda MrefuUtafiti 27
- Kansari ya MayaiUtafiti 27
- Kushindwa kwa MoyoUtafiti 26
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.